These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27355347)

  • 41. Test for rare variants by environment interactions in sequencing association studies.
    Lin X; Lee S; Wu MC; Wang C; Chen H; Li Z; Lin X
    Biometrics; 2016 Mar; 72(1):156-64. PubMed ID: 26229047
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An adaptive strategy for association analysis of common or rare variants using entropy theory.
    Li YM; Xu C; Xiang Y; Peng C; Deng HW
    J Hum Genet; 2017 Aug; 62(8):777-781. PubMed ID: 28381878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improving power of genome-wide association studies with weighted false discovery rate control and prioritized subset analysis.
    Lin WY; Lee WC
    PLoS One; 2012; 7(4):e33716. PubMed ID: 22496761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calculating the statistical significance of rare variants causal for Mendelian and complex disorders.
    Rao AR; Nelson SF
    BMC Med Genomics; 2018 Jun; 11(1):53. PubMed ID: 29898714
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Robust and Powerful Affected Sibpair Test for Rare Variant Association.
    Lin KH; Zöllner S
    Genet Epidemiol; 2015 Jul; 39(5):325-33. PubMed ID: 25966809
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical applications of molecular genetic discoveries.
    Marian AJ
    Transl Res; 2016 Feb; 168():6-14. PubMed ID: 26548329
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Power Analysis for Genetic Association Test (PAGEANT) provides insights to challenges for rare variant association studies.
    Derkach A; Zhang H; Chatterjee N
    Bioinformatics; 2018 May; 34(9):1506-1513. PubMed ID: 29194474
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Where is the causal variant? On the advantage of the family design over the case-control design in genetic association studies.
    Dandine-Roulland C; Perdry H
    Eur J Hum Genet; 2015 Oct; 23(10):1357-63. PubMed ID: 25585700
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two adaptive weighting methods to test for rare variant associations in family-based designs.
    Fang S; Sha Q; Zhang S
    Genet Epidemiol; 2012 Jul; 36(5):499-507. PubMed ID: 22674630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Benchmarking the performance of Pool-seq SNP callers using simulated and real sequencing data.
    Guirao-Rico S; González J
    Mol Ecol Resour; 2021 May; 21(4):1216-1229. PubMed ID: 33534960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Measuring missing heritability: inferring the contribution of common variants.
    Golan D; Lander ES; Rosset S
    Proc Natl Acad Sci U S A; 2014 Dec; 111(49):E5272-81. PubMed ID: 25422463
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of Rare Genetic Variations and Their Implications in NGS-data Interpretation.
    Cho Y; Lee CH; Jeong EG; Kim MH; Hong JH; Ko Y; Lee B; Yun G; Kim BJ; Jung J; Jung J; Lee JS
    Sci Rep; 2017 Aug; 7(1):9810. PubMed ID: 28851938
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hierarchical Bayesian model for rare variant association analysis integrating genotype uncertainty in human sequence data.
    He L; Pitkäniemi J; Sarin AP; Salomaa V; Sillanpää MJ; Ripatti S
    Genet Epidemiol; 2015 Feb; 39(2):89-100. PubMed ID: 25395270
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Fast Association Test for Identifying Pathogenic Variants Involved in Rare Diseases.
    Greene D; ; Richardson S; Turro E
    Am J Hum Genet; 2017 Jul; 101(1):104-114. PubMed ID: 28669401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Utilizing the Jaccard index to reveal population stratification in sequencing data: a simulation study and an application to the 1000 Genomes Project.
    Prokopenko D; Hecker J; Silverman EK; Pagano M; Nöthen MM; Dina C; Lange C; Fier HL
    Bioinformatics; 2016 May; 32(9):1366-72. PubMed ID: 26722118
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An optimum projection and noise reduction approach for detecting rare and common variants associated with complex diseases.
    Turkmen A; Lin S
    Hum Hered; 2012; 74(1):51-60. PubMed ID: 23154579
    [TBL] [Abstract][Full Text] [Related]  

  • 57. General framework for meta-analysis of rare variants in sequencing association studies.
    Lee S; Teslovich TM; Boehnke M; Lin X
    Am J Hum Genet; 2013 Jul; 93(1):42-53. PubMed ID: 23768515
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A haplotype-based framework for group-wise transmission/disequilibrium tests for rare variant association analysis.
    Chen R; Wei Q; Zhan X; Zhong X; Sutcliffe JS; Cox NJ; Cook EH; Li C; Chen W; Li B
    Bioinformatics; 2015 May; 31(9):1452-9. PubMed ID: 25568282
    [TBL] [Abstract][Full Text] [Related]  

  • 59. False discovery rates for rare variants from sequenced data.
    Capanu M; Seshan VE
    Genet Epidemiol; 2015 Feb; 39(2):65-76. PubMed ID: 25556339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
    Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
    BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.